期刊文献+

2型糖尿病肾病患者血脂和同型半胱氨酸的变化及其相关性研究 被引量:2

Clinical significance of determination of blood lipid levels and serum homocysteinemia levels in patients with type 2 diabetic nephropathy
下载PDF
导出
摘要 目的探讨血脂和同型半胱氨酸(HCY)在2型糖尿病肾病(T2DN)中的变化,并探讨其与尿白蛋白排泄率(UAER)之间的关系。方法根据尿UAER将169例2型糖尿病(T2DM)患者分为单纯糖尿病组(SDM组)、早期糖尿病肾病组(EDN组)和临床糖尿病肾病组(CDN组),45例体检健康者作为健康对照组,分别测定血脂及HCY水平。结果与健康对照组比较,T2DM3组患者血脂、HCY的差异有统计学意义(P〈O.05);与SDM组比较,EDN组和CDN组Lp(a)、HCY的差异有统计学意义(P〈0.05);与EDN组比较,CDN组Lp(a)、HCY的差异有统计学意义(P〈0.05)。Lp(a)和HCY分别与UAER呈正相关(r分别为0.496、0.502,P〈0.05)。结论血清HCY及Lp(a)水平随着UAER的增加而升高,两者与UAER之间关系密切,可能与糖尿病肾病的进展有关。 Objective To study the changes of blood lipid levels and serum homocysteinemia (HCY) levels and to investigate their relationship with urinary albumin excretion rate (UAER) in patients with type 2 diabetic nephropathy (T2DN). Methods According to the result of UAER, 169 patients with type 2 diabetes mellitus (T2DM) were divided into simple diabetes mellitus(SDM), early diabetic nephropathy(EDN) group and clinical diabetic nephropathy(CDN) group, and 45 healthy people were employed as controls. The levels of blood lipid and serum HCY of all groups were examined. Results There were significantly statistical difference of blood lipid and HCY levels in three T2DM groups as compared with that of control group (P〈0.05). Lp(a) and HCY levels in EDN and CDN groups were significantly higher than those in SDM group (P〈0.05), and Lp(a) and HCY levels in CDN group were significantly higher than those in EDN group (P〈0.05). Lp(a) and HCY were positively correlated with UAER (r=0.496, 0. 502 respectively,P〈0.05). Conclusion The levels of serum Lp(a) and HCY in DN were increased with the increment of UAER, and they had a close rela- tionship with UAER. Increment of Lp(a) and HCY might be associated with the progression of DN.
出处 《国际检验医学杂志》 CAS 2007年第9期799-801,共3页 International Journal of Laboratory Medicine
关键词 同型半胱氨酸 血脂 2型糖尿病 糖尿病肾病 Homocysteinemia (HCY) Blood lipid Type 2 diabetes mellitus (T2DM) Diabetic nephropathy (DN)
  • 相关文献

参考文献8

  • 1Fujita H, Narita T, Ito S. Abnormality in urinary protein excretion in Japanese men with impaired glucose tolerance [J]. Diabetes Care, 1999, 22(5): 823-826.
  • 2Wanjohi FW, Otieno FC, Ogola EN, et al. Nephropathy in patients with recently diagnosed type 2 diabetes mellitus in black Africans[J]. East Afr Med J, 2002, 79(8): 399-404.
  • 3Varghese A, Deepa R, Rema M, et al. Prevalence of microalbuminuria in type 2 diabetes mellitus at a diabetes centre in southern India [J]. Postgrad Med J, 2001, 77(908): 399-402.
  • 4Kim YI, Kim CH, Choi CS, et al. Microalbuminuria is associated with the insulin resistance syndrome independent of hypertension and type 2 diabetes in the Korean population [J]. Diabetes Res Clin Pract, 2001, 52(2): 145-152.
  • 5Orr P, Hobgood A, Coberley S, et al. Improvement of LDL-C laboratory values achieved by participation in a cardiac or diabetes disease management program [J]. Dis Manag, 2006, 9(6): 360- 370.
  • 6Aso Y, Yoshida N, Okumura K, et al. Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia [J]. Clin Chim Acta, 2004, 348(1-2): 139-145.
  • 7杨国庆,陆菊明,郑华,马芳玲,邹效漫,潘长玉.胰岛素治疗后血糖控制与2型糖尿病患者血浆同型半胱氨酸的关系[J].中华内科杂志,2006,45(1):34-37. 被引量:15
  • 8Carlsen SM, Foiling I, Grill V, et al. Metformin increases total serum homocysteine levels in non-diabetic male patients with coronary heart disease [J]. Scand J Clin Lab Invest, 1997, 57(6): 521-527.

二级参考文献13

  • 1Emoto M,Kanda H,Shoji T,et al.Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes.Diabetes Care,2001,24:533-538.
  • 2Pongchaidecha M,Srikusalanukul V,Chattananon A,et al.Effect of metformin on plasma homocysteine,vitamin B12 and folic acid:a cross-sectional study in patients with type 2 diabetes mellitus.J Med Assoc Thai,2004,87:780-787.
  • 3Genest J,Frohlich J,Steiner G.Effect of fenofibrate-mediated increase in plasma homocysteine on the progression of coronary artery disease in type 2 diabetes mellitus.Am J Cardiol,2004,93:848-853.
  • 4Hoogeveen EK,Kostense PJ,Beks PJ,et al.Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease,especially in non-insulin dependent diabetes mellitus:a population-based study.Arterioscler Thromb Vasc Biol,1998,18:133-138.
  • 5Carlsen SM,Folling I,Grill V,et al.Metformin increase total serum homocysteine levels in non-diabetic male patients with coronary heart disease.Scand J Clin Lab Invest,1997,57:521-527.
  • 6Gallistl S,Sudi K,Mangge H,et al.Insulin is an independent correlate of plasma homocysteine levels in obese children and adolescents.Diabetes Care,2000,23:1348-1352.
  • 7Chan NN.Homocysteine and insulin levels in type 2 diabetic patients.Diabetes Care,2000,23:1041-1042.
  • 8Jacobs RL,House JD,Brosnan ME,et al.Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat.Diabetes,1998,47:1967-1970.
  • 9Gursu MF,Baydas G,Cikim G,et al.Insulin increases homocysteine levels in a dose-dependent manner in diabetic rats.Arch Med Res,2002,33:305-307.
  • 10Nagai Y,Takamura T,Nohara E,et al.Acute hyperinsulinemia reduces plasma concentration of homocysteine in healthy men.Diabetes Care,1999,22:1004.

共引文献14

同被引文献15

引证文献2

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部